Literature DB >> 31576310

TNM in non-small cell lung cancer: a staging system for all oncologists or just for surgeons?

David Ball1.   

Abstract

Entities:  

Year:  2019        PMID： 31576310      PMCID： PMC6685887          DOI： 10.21037/atm.2019.04.84

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  10 in total

1.  TNM seventh edition: what's new, what's changed: communication from the International Union Against Cancer and the American Joint Committee on Cancer.

Authors:  Leslie H Sobin; Carolyn C Compton
Journal:  Cancer       Date:  2010-11-15       Impact factor: 6.860

2.  A system for the clinical staging of lung cancer.

Authors:  C F Mountain; D T Carr; W A Anderson
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1974-01

3.  The IASLC lung cancer staging project: the new database to inform the eighth edition of the TNM classification of lung cancer.

Authors:  Ramón Rami-Porta; Vanessa Bolejack; Dorothy J Giroux; Kari Chansky; John Crowley; Hisao Asamura; Peter Goldstraw
Journal:  J Thorac Oncol       Date:  2014-11       Impact factor: 15.609

4.  The IASLC Lung Cancer Staging Project: Proposals for the Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer.

Authors:  Ramón Rami-Porta; Vanessa Bolejack; John Crowley; David Ball; Jhingook Kim; Gustavo Lyons; Thomas Rice; Kenji Suzuki; Charles F Thomas; William D Travis; Yi-Long Wu
Journal:  J Thorac Oncol       Date:  2015-07       Impact factor: 15.609

5.  Effect of tumor size on prognosis in patients treated with radical radiotherapy or chemoradiotherapy for non-small cell lung cancer. An analysis of the staging project database of the International Association for the Study of Lung Cancer.

Authors:  David Ball; Alan Mitchell; Dori Giroux; Ramon Rami-Porta
Journal:  J Thorac Oncol       Date:  2013-03       Impact factor: 15.609

6.  The complex relationship between lung tumor volume and survival in patients with non-small cell lung cancer treated by definitive radiotherapy: a prospective, observational prognostic factor study of the Trans-Tasman Radiation Oncology Group (TROG 99.05).

Authors:  David L Ball; Richard J Fisher; Bryan H Burmeister; Michael G Poulsen; Peter H Graham; Michael G Penniment; Shalini K Vinod; Hedley E Krawitz; David J Joseph; Greg C Wheeler; Bev E McClure
Journal:  Radiother Oncol       Date:  2013-01-16       Impact factor: 6.280

7.  Tumor volume: a basic and specific response predictor in radiotherapy.

Authors:  H H Dubben; H D Thames; H P Beck-Bornholdt
Journal:  Radiother Oncol       Date:  1998-05       Impact factor: 6.280

8.  Comparison of 7th and 8th editions of the UICC/AJCC TNM staging for non-small cell lung cancer in a non-metastatic North American cohort undergoing primary radiation treatment.

Authors:  Rashmi Koul; Shrinivas Rathod; Arbind Dubey; Bashir Bashir; Amitava Chowdhury
Journal:  Lung Cancer       Date:  2018-06-30       Impact factor: 5.705

9.  The IASLC Lung Cancer Staging Project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer.

Authors:  Ramón Rami-Porta; David Ball; John Crowley; Dorothy J Giroux; James Jett; William D Travis; Masahiro Tsuboi; Eric Vallières; Peter Goldstraw
Journal:  J Thorac Oncol       Date:  2007-07       Impact factor: 15.609

10.  Lung cancer prognostic index: a risk score to predict overall survival after the diagnosis of non-small-cell lung cancer.

Authors:  Marliese Alexander; Rory Wolfe; David Ball; Matthew Conron; Robert G Stirling; Benjamin Solomon; Michael MacManus; Ann Officer; Sameer Karnam; Kate Burbury; Sue M Evans
Journal:  Br J Cancer       Date:  2017-07-20       Impact factor: 7.640
  10 in total
  3 in total

1.  Identification of a 7-miRNA signature for predicting the prognosis of patients with lung adenocarcinoma.

Authors:  Ruijun Liu; Zhiyi Guo; Jia Huang; Jiantao Li; Qiang Tan; Qingquan Luo
Journal:  Exp Biol Med (Maywood)       Date:  2022-01-22

Review 2.  Neoadjuvant apatinib plus S-1 in locally advanced pulmonary adenocarcinoma: A case report and review of the literature.

Authors:  Chu Zhang; Xiang Wang; Miao Zhang; Dong Liu; Dun-Peng Yang
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.889

3.  A Seven-Long Non-coding RNA Signature Improves Prognosis Prediction of Lung Adenocarcinoma: An Integrated Competing Endogenous RNA Network Analysis.

Authors:  Rang Li; Kedong Han; Dehua Xu; Xiaolin Chen; Shujin Lan; Yuanjun Liao; Shengnan Sun; Shaoqi Rao
Journal:  Front Genet       Date:  2021-01-28       Impact factor: 4.599
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.